| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 10/21/2004 | WO1995027066A9 Dna encoding ubiquitin conjugating enzymes |
| 10/21/2004 | US20040209368 Preparing transgenic bacteria with enhanced ubiquinone production |
| 10/21/2004 | US20040209345 cyanide resistant; cultured from rhodococcus; for producing 2-hydroxy-4-methylthiobutyroamide from hydroxy nitrile compounds |
| 10/21/2004 | US20040209337 Synthesis of 1,2,3,4-tetrahydroxybenzenes from biomass-derived carbon |
| 10/21/2004 | US20040209335 Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455 |
| 10/21/2004 | US20040209333 administering subtilisins obtained from grampositive bacterial residues that vitamin k2 has been removed using chitosan |
| 10/21/2004 | US20040208895 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 10/21/2004 | US20040208878 Treatment of acute lung injury, fibrosis and metastasis with antagonists of alphabetav6 |
| 10/21/2004 | US20040208863 Anti-inflammatory activity from lactic acid bacteria |
| 10/21/2004 | US20040208851 Immunization by inoculation of DNA transcription unit |
| 10/20/2004 | EP1469080A1 Novel microorganism, its product and utilization thereof |
| 10/20/2004 | EP1469078A1 Method for preparing Sporodiobolus strains with an improved coenzyme Q10 production |
| 10/20/2004 | EP1469074A1 Human calcium channel compositions and methods |
| 10/20/2004 | EP1468075A1 Novel lactobacillus sp. strain and use thereof |
| 10/20/2004 | EP1467625A1 Adhesion inhibition of moulds |
| 10/20/2004 | EP1212337B1 Pesticidal macrolides |
| 10/20/2004 | EP0967271B1 Novel carbonyl reductase, gene that encodes the same, and method of utilizing these |
| 10/20/2004 | EP0859050B1 Alkaline protease, process for the production thereof, use thereof, and microorganism producing the same |
| 10/20/2004 | EP0739416A4 Enzyme based bioremediation |
| 10/20/2004 | EP0734451B1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
| 10/20/2004 | EP0732939B1 Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18 |
| 10/20/2004 | EP0722461B1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 10/20/2004 | EP0631620B1 Mutagenesis and selection methoden in the same host cells |
| 10/20/2004 | CN1539022A Viral drug susceptibility testing |
| 10/20/2004 | CN1539018A Surface expression vectors having pgs BCA the gene coding poly-gamma-glutamate synthetase, and method for expression of target protein at the surface of microorganism using the vector |
| 10/20/2004 | CN1537935A 培养物 Culture |
| 10/20/2004 | CN1172003C Method for producing N-acetylneuraminic acid |
| 10/20/2004 | CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use |
| 10/20/2004 | CN1171902C Antisercretory factor petides regulating pathological permeability changes |
| 10/20/2004 | CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same |
| 10/19/2004 | US6806360 Nucleic acids encoding human tissue factor inhibitor |
| 10/19/2004 | US6806068 Nucleotide sequences which encode the pfk gene |
| 10/19/2004 | US6806061 G protein-coupled receptor gene and methods of use therefor |
| 10/19/2004 | US6805864 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 10/19/2004 | US6805859 To provide a plant not showing livestock toxicity due to symbiotic fungi with which it is infected, and having strong resistance to pests, symbiotic fungus |
| 10/19/2004 | CA2323096C Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 10/19/2004 | CA2059898C Biologically active bacillus thuringiensis isolates and gene encoding a coleopteran-active toxin |
| 10/19/2004 | CA1341459C Modified fibrinolytic enzymes |
| 10/17/2004 | CA2463344A1 Process for producing sporidiobolus ruineniae strains with improved coenzyme q10 production |
| 10/14/2004 | WO2004087891A1 Lactobacillus fermentum strain and uses thereof |
| 10/14/2004 | WO2004087746A2 Staphylococcus epidermidis antigens |
| 10/14/2004 | US20040205835 Jak kinases and regulation of cytokine signal transduction |
| 10/14/2004 | US20040204568 Comprises nucleotide sequences coding cell adhesion molecules for use in the diagnosis, prevention and treatment of autoimmune and cell proliferative disorders |
| 10/14/2004 | US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203057 Novel DNA cloning method |
| 10/14/2004 | US20040203039 Attenuated salmonella SP12 mutants as antigen carriers |
| 10/14/2004 | US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 10/14/2004 | US20040202672 Dermatomycosis vaccine |
| 10/14/2004 | US20040202662 Humanised antibodies |
| 10/14/2004 | US20040202657 Humanized anti-CD3 specific antibodies |
| 10/14/2004 | US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy |
| 10/14/2004 | CA2526861A1 Lactobacillus fermentum strain and uses thereof |
| 10/14/2004 | CA2520868A1 Staphylococcus epidermidis antigens |
| 10/13/2004 | EP1466966A1 Apparatus and process of lysis by biological ultrasounds of cells |
| 10/13/2004 | EP1465990A2 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 10/13/2004 | EP1465988A2 Myo-inositol oxygenases |
| 10/13/2004 | EP1465898A1 Biocidal compounds and their preparation |
| 10/13/2004 | EP1257584B1 Humanized antibodies that sequester amyloid beta peptide |
| 10/13/2004 | EP1179095A4 Methods for producing modified nucleic acid molecules |
| 10/13/2004 | EP1171631B1 Assay for detecting phospho-n-acetylmuramyl-pentapeptide translocase activity |
| 10/13/2004 | EP1102858B1 Cell lines for the propagation of mutated herpes viruses |
| 10/13/2004 | EP0851933B1 Plant gene encoding acetyl coenzyme a carboxylase biotin carboxylase carrier protein |
| 10/13/2004 | EP0850314B1 Production of microbial cellulose using a rotating disk film bioreactor |
| 10/13/2004 | EP0817847B1 Il-17 receptor |
| 10/13/2004 | EP0788549B1 Regulatory nucleic acid sequences and uses thereof |
| 10/13/2004 | EP0739353B1 Bacterial receptor structures |
| 10/13/2004 | EP0688361B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | CN1537163A Subtilase variants |
| 10/13/2004 | CN1537160A Leguminous bacterium having potentiated mitrogen fixation ability |
| 10/13/2004 | CN1535971A Fermentation preparation method of cell inhibitor and its crystal form |
| 10/13/2004 | CN1170941C Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 10/13/2004 | CN1170935C Astaxanthin synthetic enzyme |
| 10/13/2004 | CN1170926C Use of stem cell factor and soluble interleukin-6 receptor for ex vivo expansion of hematopoietic multipotential cells |
| 10/13/2004 | CN1170594C 弯曲菌疫苗 Campylobacter vaccine |
| 10/12/2004 | US6803449 Polypeptide for use in the diagnosis and treatment viral diseases |
| 10/12/2004 | US6803218 Using thermophilic organisms; which catalytically ferment glycerol to 1,3-propanediol; cloning polynucleotides; solid phase synthesis |
| 10/12/2004 | US6803212 Low oxygen affinity mutant hemoglobins |
| 10/12/2004 | US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM |
| 10/12/2004 | CA2218761C Probe, nucleic acid sequences, method particularly suitable for detecting and identifying yeasts, and genetic tools therefor |
| 10/12/2004 | CA1341458C Modified human t-pa |
| 10/07/2004 | WO2004086036A1 Method of screening substance interacting with abc protein |
| 10/07/2004 | WO2004084936A2 Modified free-living microbes, vaccine compositions and methods of use thereof |
| 10/07/2004 | WO2004013297A3 Manzamine-producing actinomycetes |
| 10/07/2004 | WO2004007709A3 Production of polyketides |
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 10/07/2004 | WO2003066818A3 Secretion, transcription and sporulation genes in bacillus clausii |
| 10/07/2004 | US20040197918 Epression vector coding replication protein for transformation and generation of coryneform bacterium that can grow at an elevated temperature; fermentation of amino acid sequences for use in cosmetics, nutrients and medicines |
| 10/07/2004 | US20040197915 Transgenic tobacco expressing phosphoenol pyruvate carboxylase of poaceae; enhanced light processing capabilites |
| 10/07/2004 | US20040197894 Comprises proteolytic polypeptide with enhanced wash performance, thermal stability, storage stability and catalytic activity for improving laundering and diswashing detergents |
| 10/07/2004 | US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine. |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197772 catalyzes the hydrolysis of nitrile-containing substrates to carboxylic acids under mild reaction conditions; solid phase synthesis |
| 10/07/2004 | US20040197343 Attenuated for cell proliferation; repair nucleic acids; vaccines against cancer, infections |
| 10/07/2004 | US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents |
| 10/07/2004 | CA2515298A1 Modified free-living microbes, vaccine compositions and methods of use thereof |